Markets:

Overview

News

Currencies

International

Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

58.91 -0.28 (-0.47%)

Streaming Delayed Price Updated: 11:39 AM EST, Dec 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 ↗

January 10, 2023

Via Benzinga

Bio-Techne: Q1 Earnings Insights ↗

November 01, 2022

Bio-Techne (NASDAQ:TECH) reported its Q1 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Bio-Techne Q4 Earnings ↗

August 04, 2022

Bio-Techne (NASDAQ:TECH) reported its Q4 earnings results on Thursday, August 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗

December 15, 2022

The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

Recap: Bio-Techne Q3 Earnings ↗

May 04, 2022

Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Bio-Techne Clocks 17% Organic Revenue Growth In Q2, Announces $400M Share Buyback ↗

February 01, 2022

Bio-Techne Corporation (NASDAQ: TECH) has posted Q2 FY22 s

Via Benzinga

Earnings Scheduled For November 2, 2021 ↗

November 02, 2021

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Our 7 Top Biotech Stock Picks for 2023 ↗

December 09, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Monday ↗

September 19, 2022

On Monday, 429 stocks made new 52-week lows.

Via Benzinga

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 16, 2022

During Friday's session, 574 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

September 14, 2022

During Wednesday's session, 265 companies made new 52-week lows.

Via Benzinga

NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks ↗

August 16, 2022

Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Tackling Recurring Health Conditions Offers Hope to Patients

June 21, 2022

Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...

Via FinancialNewsMedia

Stocks That Hit 52-Week Lows On Tuesday ↗

June 14, 2022

On Tuesday, 951 companies hit new 52-week lows.

Via Benzinga

7 Defensive Growth Stocks to Buy for a Shaky Market ↗

May 21, 2022

These are the best defensive growth stocks to invest in now. Each of these can make great investments if/when the market sours.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 ↗

April 25, 2022

Via Benzinga

7 Superior Stocks That Smart Investors Will Buy on the Dip ↗

February 07, 2022

The recent sell-off presents long-term investors with many robust stocks to buy on the dip. These seven provide a start.

Via InvestorPlace

10 Biggest Price Target Changes For Wednesday ↗

February 02, 2022

Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading.

Via Benzinga

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program ↗

February 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Here's How Much You Would Have Made Owning Bio-Techne Stock In The Last 5 Years ↗

December 03, 2021

Bio-Techne (NASDAQ:TECH) has outperformed the market over the past 5 years by 17.84% on an annualized basis. Buying $1,000.00 In TECH: 5 years ago, an investor could have...

Via Benzinga

Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript ↗

November 02, 2021

TECH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

Bio-Techne's Earnings: A Preview ↗

November 01, 2021

Bio-Techne (NASDAQ:TECH) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Data; Crude Oil Gains 1% ↗

September 15, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped nearly 300 points in the previous week. Investors are awaiting earnings...

Via Benzinga

Topics Stocks

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.